SequelSEC

Health In Tech, Inc. HIT

Insurance Agents, Brokers & Service · CIK 0002019505 · Fiscal year ends 1231 · Insurer

AnnualQuarterlyTTM
Revenue
$8.06M
Fiscal year ended 2026-06-30
Net income
-$2.51M
Fiscal year ended 2026-06-30
Total assets
$29.63M
Fiscal year ended 2026-06-30

Health In Tech, Inc. (HIT) reported revenue of $8.06M and net income of -$2.51M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Health In Tech, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Insurance Agents, Brokers & Service.

Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.

Income

Health In Tech, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Revenue$8.06M$8.77M$7.51M$8.49M$9.31M$8.01M$4.90M$4.46M$5.00M$5.12M
Cost of revenue$4.13M$4.26M$3.38M$3.35M$3.00M$2.66M$1.11M$979.63K$974.73K$989.91K
Gross profit$3.92M$4.51M$4.13M$5.14M$6.31M$5.36M$3.80M$3.48M$4.03M$4.14M
Operating incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net income-$2.51M-$1.59M-$302.56K$452.18K$630.63K$498.59K-$144.15K$376.09K$338.01K$100.54K
Research & development$875.81K$920.40K$213.11K$235.82K$582.61K$537.72K$633.65K$718.42K$701.63K$760.20K
Weighted-average diluted sharesshares 62.83Mshares 57.35MUnavailableshares 58.77Mshares 55.63Mshares 57.00Mshares 1.89Mshares 51.77Mshares 51.77Mshares 51.77M
Pretax income-$3.32M-$2.07M-$443.74K$600.22K$833.27K$684.42K-$110.75K$406.74K$401.28K$191.73K
Income tax expense-$809.89K-$480.07K-$141.18K$148.05K$202.64K$185.83K$33.40K$30.65K$63.27K$91.20K
Diluted EPS$-0.04$-0.03$-0.01$0.01$0.01$0.01$-0.01$0.01$0.01Unavailable
Selling, general & administrative$6.48M$5.75M$4.09M$4.41M$5.00M$4.34M$3.48M$2.32M$2.79M$3.04M
General & administrative$4.27M$3.46M$3.18M$3.45M$3.78M$3.25M$2.85M$1.81M$1.82M$2.00M
Selling & marketing$2.22M$2.29M$906.21K$962.57K$1.23M$1.09M$632.06K$508.47K$974.52K$1.04M

Balance

Health In Tech, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$6.51M$10.33M$7.67M$8.02M$8.14M$7.58M$7.85MUnavailableUnavailableUnavailable
Total assets$29.63M$28.97M$23.09M$22.76M$22.18M$21.33M$15.77MUnavailableUnavailableUnavailable
Current assets$21.78M$22.09M$16.16M$15.05M$14.85M$15.57M$10.78MUnavailableUnavailableUnavailable
Total liabilities$10.01M$7.36M$5.98M$5.60M$5.75M$7.17M$2.60MUnavailableUnavailableUnavailable
Current liabilities$9.99M$7.05M$5.16M$5.24M$5.39M$6.75M$2.13MUnavailableUnavailableUnavailable
Total equity incl. NCI$19.62M$21.60M$17.11M$17.16M$16.42M$14.16M$13.17M$6.91M$6.53M$6.19M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$8.55M$3.74M$756.29K$868.63K$1.28M$2.11M$1.65MUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

Health In Tech, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow-$2.91M-$3.32M$451.21K$673.97K$1.48M$527.35K-$531.17K$2.12M$1.27M-$680.21K
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flow-$596.99K-$362.13K-$767.71K-$744.84K-$909.90K-$703.48K-$542.12K-$67.28K-$93.96K-$133.39K
Financing cash flow-$301.08K$6.34M-$37.36K-$43.68K-$8.25K-$98.09K$7.18M-$2.47M-$368.91K-$243.21K
Net change in cashUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Stock-based compensation$959.32K$366.56K$76.73K$292.55K$707.96K$493.17KUnavailableUnavailableUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$320.32K$403.47K$410.63K$217.98K$135.98K$135.98K$135.98K$135.58K$134.79K$134.79K

Derived

Health In Tech, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross margin48.7%51.4%55.0%60.6%67.7%66.8%77.4%78.0%80.5%80.7%
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenue11.9%4.2%1.0%3.4%7.6%6.2%UnavailableUnavailableUnavailableUnavailable
Current ratio2.18x3.13x3.13x2.87x2.76x2.31x5.06xUnavailableUnavailableUnavailable
Revenue YoY growth-13.5%9.4%53.1%90.4%86.2%56.4%UnavailableUnavailableUnavailableUnavailable
Net margin-31.2%-18.1%-4.0%5.3%6.8%6.2%-2.9%8.4%UnavailableUnavailable
R&D / revenue10.9%10.5%2.8%2.8%6.3%6.7%12.9%16.1%14.0%14.8%
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailable24.7%24.3%27.2%Unavailable7.5%15.8%47.6%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HIT in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-25View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-08View SEC filing
10-Q · Filed 2025-05-09View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.